Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-04

FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Original Application (Bionpharma Inc.,)

View source ↗

Summary

FDA approved an original application for a generic combination of doxylamine succinate and pyridoxine hydrochloride for nausea and vomiting in pregnancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (doxylamine succinate and pyridoxine hydrochloride)

Snippet

ORIG AP for DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE)